US Capitol Capsule: White House warns FDA budget cuts would severely limit agency
This article was originally published in Scrip
Executive Summary
If the Senate adopts legislation passed by the House on 16 June that seeks to cut the US FDA's discretionary funding for fiscal year 2012 by $285 million, or 11.5% below FY 2011's level, the agency's ability to protect the public health, ensure food and medical products are safe and improve Americans' access to generics and biosimilars would be severely limited, the White House Office of Management and Budget asserted last week.